In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck

Gregory S. Waters, George J. Burke, James H. Corley, John P. Wei

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Technetium-99M-sestamibi (Tc-99M-sestamibi) has recently been proven to be a sensitive and specific agent for imaging of parathyroid disease; however, the selective nature of its uptake by different tissues has not been investigated. Fifteen consecutive patients undergoing neck exploration for hyperparathyroidism were given 3 to 15 mCi of Tc-99M-sestamibi at various times before surgery, and at the time of exploration, samples of parathyroid tissue, blood, fat, muscle, and thyroid were taken from the neck. All samples were carefully weighed and counts of radioactivity were measured. Activity was normalized to counts per gram of tissue and counts of radioactivity were compared using a multiple range analysis of variance test. Mean counts per gram (±SE) in abnormal parathyroid tissue (adenomas and hyperplastic glands; 1.1 x 106 ± 2.7 x 106) were significantly higher than in any of the other tissues measured (P < 0.05); thyroid, 7.0 x 104 ± 1.6 x 104; muscle, 8.9 x 104 ± 2.1 x 104; fat, 2.1 x 104 ± 4.2 x 103; and blood, 9.8 x 103 ± 2.3 x 103. Mean ratios of counts (±SE) of abnormal parathyroid tissue to other tissues were found to be as follows: thyroid, 35.3 ± 12.6; muscle, 17.4 ± 6.2; fat, 80.7 ± 20.0; and blood, 161.0 ± 31.6. From these data, Tc-99M-sestamibi clearly exhibits significantly higher uptake in abnormal parathyroid tissue relative to other tissues measured in the neck. This increased uptake in parathyroid gland tissue accounts for the utility of Tc- 99M-sestamibi in localization studies for hyperparathyroidism. Quantification of in vivo uptake of Tc-99M-sestamibi may help refine techniques for improved localization of hyperfunctional parathyroid glands.

Original languageEnglish (US)
Pages (from-to)195-198
Number of pages4
JournalAmerican Surgeon
Volume63
Issue number2
StatePublished - Feb 11 1997

Fingerprint

Technetium Tc 99m Sestamibi
Parathyroid Glands
Neck
Thyroid Gland
Hyperparathyroidism
Fats
Muscles
Radioactivity
Parathyroid Diseases
Parathyroid Neoplasms
Analysis of Variance

ASJC Scopus subject areas

  • Surgery

Cite this

In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck. / Waters, Gregory S.; Burke, George J.; Corley, James H.; Wei, John P.

In: American Surgeon, Vol. 63, No. 2, 11.02.1997, p. 195-198.

Research output: Contribution to journalArticle

Waters, Gregory S. ; Burke, George J. ; Corley, James H. ; Wei, John P. / In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck. In: American Surgeon. 1997 ; Vol. 63, No. 2. pp. 195-198.
@article{d4c8086308f2466b81b4b0d7dd68ce23,
title = "In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck",
abstract = "Technetium-99M-sestamibi (Tc-99M-sestamibi) has recently been proven to be a sensitive and specific agent for imaging of parathyroid disease; however, the selective nature of its uptake by different tissues has not been investigated. Fifteen consecutive patients undergoing neck exploration for hyperparathyroidism were given 3 to 15 mCi of Tc-99M-sestamibi at various times before surgery, and at the time of exploration, samples of parathyroid tissue, blood, fat, muscle, and thyroid were taken from the neck. All samples were carefully weighed and counts of radioactivity were measured. Activity was normalized to counts per gram of tissue and counts of radioactivity were compared using a multiple range analysis of variance test. Mean counts per gram (±SE) in abnormal parathyroid tissue (adenomas and hyperplastic glands; 1.1 x 106 ± 2.7 x 106) were significantly higher than in any of the other tissues measured (P < 0.05); thyroid, 7.0 x 104 ± 1.6 x 104; muscle, 8.9 x 104 ± 2.1 x 104; fat, 2.1 x 104 ± 4.2 x 103; and blood, 9.8 x 103 ± 2.3 x 103. Mean ratios of counts (±SE) of abnormal parathyroid tissue to other tissues were found to be as follows: thyroid, 35.3 ± 12.6; muscle, 17.4 ± 6.2; fat, 80.7 ± 20.0; and blood, 161.0 ± 31.6. From these data, Tc-99M-sestamibi clearly exhibits significantly higher uptake in abnormal parathyroid tissue relative to other tissues measured in the neck. This increased uptake in parathyroid gland tissue accounts for the utility of Tc- 99M-sestamibi in localization studies for hyperparathyroidism. Quantification of in vivo uptake of Tc-99M-sestamibi may help refine techniques for improved localization of hyperfunctional parathyroid glands.",
author = "Waters, {Gregory S.} and Burke, {George J.} and Corley, {James H.} and Wei, {John P.}",
year = "1997",
month = "2",
day = "11",
language = "English (US)",
volume = "63",
pages = "195--198",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "2",

}

TY - JOUR

T1 - In vivo uptake of technetium-99M-sestamibi by parathyroid glands in comparison to surrounding tissues of the neck

AU - Waters, Gregory S.

AU - Burke, George J.

AU - Corley, James H.

AU - Wei, John P.

PY - 1997/2/11

Y1 - 1997/2/11

N2 - Technetium-99M-sestamibi (Tc-99M-sestamibi) has recently been proven to be a sensitive and specific agent for imaging of parathyroid disease; however, the selective nature of its uptake by different tissues has not been investigated. Fifteen consecutive patients undergoing neck exploration for hyperparathyroidism were given 3 to 15 mCi of Tc-99M-sestamibi at various times before surgery, and at the time of exploration, samples of parathyroid tissue, blood, fat, muscle, and thyroid were taken from the neck. All samples were carefully weighed and counts of radioactivity were measured. Activity was normalized to counts per gram of tissue and counts of radioactivity were compared using a multiple range analysis of variance test. Mean counts per gram (±SE) in abnormal parathyroid tissue (adenomas and hyperplastic glands; 1.1 x 106 ± 2.7 x 106) were significantly higher than in any of the other tissues measured (P < 0.05); thyroid, 7.0 x 104 ± 1.6 x 104; muscle, 8.9 x 104 ± 2.1 x 104; fat, 2.1 x 104 ± 4.2 x 103; and blood, 9.8 x 103 ± 2.3 x 103. Mean ratios of counts (±SE) of abnormal parathyroid tissue to other tissues were found to be as follows: thyroid, 35.3 ± 12.6; muscle, 17.4 ± 6.2; fat, 80.7 ± 20.0; and blood, 161.0 ± 31.6. From these data, Tc-99M-sestamibi clearly exhibits significantly higher uptake in abnormal parathyroid tissue relative to other tissues measured in the neck. This increased uptake in parathyroid gland tissue accounts for the utility of Tc- 99M-sestamibi in localization studies for hyperparathyroidism. Quantification of in vivo uptake of Tc-99M-sestamibi may help refine techniques for improved localization of hyperfunctional parathyroid glands.

AB - Technetium-99M-sestamibi (Tc-99M-sestamibi) has recently been proven to be a sensitive and specific agent for imaging of parathyroid disease; however, the selective nature of its uptake by different tissues has not been investigated. Fifteen consecutive patients undergoing neck exploration for hyperparathyroidism were given 3 to 15 mCi of Tc-99M-sestamibi at various times before surgery, and at the time of exploration, samples of parathyroid tissue, blood, fat, muscle, and thyroid were taken from the neck. All samples were carefully weighed and counts of radioactivity were measured. Activity was normalized to counts per gram of tissue and counts of radioactivity were compared using a multiple range analysis of variance test. Mean counts per gram (±SE) in abnormal parathyroid tissue (adenomas and hyperplastic glands; 1.1 x 106 ± 2.7 x 106) were significantly higher than in any of the other tissues measured (P < 0.05); thyroid, 7.0 x 104 ± 1.6 x 104; muscle, 8.9 x 104 ± 2.1 x 104; fat, 2.1 x 104 ± 4.2 x 103; and blood, 9.8 x 103 ± 2.3 x 103. Mean ratios of counts (±SE) of abnormal parathyroid tissue to other tissues were found to be as follows: thyroid, 35.3 ± 12.6; muscle, 17.4 ± 6.2; fat, 80.7 ± 20.0; and blood, 161.0 ± 31.6. From these data, Tc-99M-sestamibi clearly exhibits significantly higher uptake in abnormal parathyroid tissue relative to other tissues measured in the neck. This increased uptake in parathyroid gland tissue accounts for the utility of Tc- 99M-sestamibi in localization studies for hyperparathyroidism. Quantification of in vivo uptake of Tc-99M-sestamibi may help refine techniques for improved localization of hyperfunctional parathyroid glands.

UR - http://www.scopus.com/inward/record.url?scp=0031033946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031033946&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 195

EP - 198

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 2

ER -